Currently Enrolling Studies
Gwinnett Biomedical Research (located in Lawrenceville, GA) is conducting COPD, Asthma and other studies on a continual basis. Please feel free to discuss opportunities of how we may help you even if you do not see it listed on the page.
Gwinnett Pulmonary Group
GPG provides Gwinnett Biomedical Research with their medical expertise and the highest quality patient safety oversight. GPG was founded in 1983 and has grown to include eight board certified Pulmonary Physicians... [Read More]
Bronchiectasis, Emphysema. For more information, please Contact Us.
Gwinnett Biomedical Research (GBR) is an organization that strives to provide for the citizens of Gwinnett County access to excellent medical care and the most recent advances in the treatment of pulmonary disease. It operates under the auspices of Gwinnett Pulmonary Group with Dr. Paul …
Frequently Asked Questions
What are clinical trials?
1Clinical studies are research studies in which real people participate as volunteers. Clinical trials are a means of developing new treatments and medications for diseases and conditions. Some of the research studies at the Clinical Center involve promising new treatments that may directly benefit patients.
Why should I participate?
2The health of millions has been improved because of advances in science and technology, and the willingness of thousands of individuals like you to take part in clinical research. The role of volunteer subjects as partners in clinical research is crucial in the quest for knowledge that will improve the health of future generations.
How much will it cost me?
3Clinical trials are free of charge to all subjects participating. All study related treatments and medication are paid for by the drug company sponsoring the study. Subjects will receive financial compensation for their time. We will never ask for your insurance information as it is not needed for your participation in a clinical trial.
Can anyone go on a study?
4For studies that test the effectiveness of a drug to treat certain symptoms (Phase II-IV), patients are selected based upon certain health criteria. Patients will qualify if they have a certain diagnosis or risk factors that the drug is intended to treat.